Halozyme Therapeutics Inc (NASDAQ:HALO)

38.80
BATS BZX Real-Time Price
As of 2:52pm ET
 +0.36 / +0.94%
Today’s Change
27.21
Today|||52-Week Range
56.40
-9.15%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 53.50, with a high estimate of 66.00 and a low estimate of 17.00. The median estimate represents a +37.89% increase from the last price of 38.80.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.43
Sales
$107.0M
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -30.25%
 
 
 
 
 
 
Growthannually 81.21%
 
 
 
 
 
 

Sales

Growthquarterly -21.55%
 
 
 
 
 
 
Growthannually 64.49%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.